Longitudinal Safety Outcomes of Anti-tumor Necrosis Factor Alpha Therapy in the Treatment of Inflammatory Bowel Disease
Related Posts
Zhao K, Vignolle GA, Labus JS, Mayer EA, Vaughan A, Dy M, Vora P, Hung MW, Vossel K, Gill C, Del Rio D, Stanton C,[...]
It is with great enthusiasm that we announce that Gregory F. Sonnenberg, PhD, has accepted the appointment as director of the UCLA Center for Research[...]
Dunn DP, Dani G, Sharma A, Ioannou GN, Taddei TH, Chang ST, Onyiuke IY, Planeta BM, Huang GD, Weiss NS, Morgan TR, Dominitz JA, Abou-Alfa[...]